AVTX
Avalo Therapeutics, Inc.NASDAQHealthcare$17.76+6.35%ClosedMarket Cap: $200.6M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
1
Sales
6
Buy/Sell Ratio
0.17
Total Bought
$0.00
Total Sold
$5.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Apr 03 | Doyle Mittie | officer: Chief Medical Officer | Sell | 679 | $16.00 | 3,622 |
| Fri Apr 03 | Doyle Mittie | officer: Chief Medical Officer | Sell | 679 | $8.04 | 148,329 |
| Fri Apr 03 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 1,780 | $17.57 | 17,338 |
| Fri Apr 03 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 7,479 | $16.83 | 25,318 |
| Fri Apr 03 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 500 | $15.86 | 32,797 |
| Fri Apr 03 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 6,200 | $17.02 | 19,118 |
| Wed Apr 01 | Jain Rita | director | Sell | 1,339 | $14.93 | 1,339 |
| Wed Apr 01 | Lind Kevin Robert | director | Sell | 1,370 | $14.93 | 1,370 |
| Tue Mar 31 | NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | Sell | 64,866 | $0.00 | 112,006 |
| Tue Mar 31 | Truex Samantha | director | Sell | 3,166 | $0.00 | 6,333 |
| Tue Mar 31 | KANTOFF AARON | director | Sell | 3,166 | $0.00 | 6,333 |
| Tue Mar 31 | KAPLAN GILLA | director | Sell | 3,166 | $0.00 | 6,333 |
| Tue Mar 31 | NEIL GARRY ARTHUR | director, officer: Chief Executive Officer | Sell | 21,892 | $13.89 | 90,114 |
| Tue Mar 31 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 24,200 | $0.00 | 41,538 |
| Wed Mar 18 | Doyle Mittie | officer: Chief Medical Officer | Sell | 19,500 | $12.65 | 214,500 |